Emily Aronin

Senior Analyst

Emily joined Valor in 2022 and serves as a Senior Analyst on the Investment Team of Valor Siren Ventures.

Prior to joining Valor, Emily assisted the commercial team at Paragon Biosciences where she actively searched for opportunities within the biotechnology market and supported commercial deals. Most recently, she worked alongside the commercial and marketing teams at Evozyne, a protein engineering company leveraging artificial intelligence and machine learning to harness the capabilities of natural biology.

Emily earned a B.B.A. in Consulting and Entrepreneurship with a concentration in Health Innovation from Emory University.